Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) EBIT (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of EBIT data on record, last reported at -$2.8 million in Q4 2019.

  • For Q4 2019, EBIT fell 30.85% year-over-year to -$2.8 million; the TTM value through Dec 2019 reached -$11.6 million, down 71.47%, while the annual FY2024 figure was -$26.7 million, 25.46% down from the prior year.
  • EBIT reached -$2.8 million in Q4 2019 per DMAC's latest filing, down from -$2.7 million in the prior quarter.
  • Across five years, EBIT topped out at -$1.3 million in Q1 2018 and bottomed at -$3.4 million in Q1 2019.